Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL2300092	德谷胰岛素利拉鲁肽注射液	Insulin Degludec;Liraglutide	Injection	Biological Products(3.3)	New Drug Application	2023-02-08		Federal Biotechnology (Zhuhai Hengqin) Co Ltd			view
CXSL2400105	德谷胰岛素利拉鲁肽注射液	Insulin Degludec;Liraglutide	Injection	Biological Products(3.3)	New Drug Application	2024-02-07		Tonghua Dongbao Pharmaceutical Co Ltd			view
CYSB2300007	德谷胰岛素利拉鲁肽注射液	Insulin Degludec;Liraglutide	Injection	Biological Products	Supplementary Application	2023-01-11		Novo Nordisk (China) Pharmaceuticals Co Ltd			view
CXSL2400772	德谷胰岛素利拉鲁肽注射液	Insulin Degludec;Liraglutide	Injection	Biological Products(3.3)	New Drug Application	2024-11-13		Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd			view
CXSL2400082	德谷胰岛素利拉鲁肽注射液	Insulin Degludec;Liraglutide	Injection	Biological Products(3.3)	New Drug Application	2024-02-01					view
CXSL2400436	德谷胰岛素利拉鲁肽注射液	Insulin Degludec;Liraglutide	Injection	Biological Products(3.3)	New Drug Application	2024-07-09		Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd			view
JYSB2400021	德谷胰岛素利拉鲁肽注射液	Insulin Degludec;Liraglutide	Injection	Biological Products	Supplementary Application	2024-02-01					view
CXSL2200411	德谷胰岛素利拉鲁肽注射液	Insulin Degludec;Liraglutide	Injection	Biological Products(3.3)	New Drug Application	2022-08-29		Tonghua Dongbao Pharmaceutical Co Ltd			view
CXSL2300515	德谷胰岛素利拉鲁肽注射液	Insulin Degludec;Liraglutide	Injection	Biological Products(3.3)	New Drug Application	2023-07-26		Jilin Huisheng Biopharmaceutical Co Ltd			view
JYSB2400035	德谷胰岛素利拉鲁肽注射液	Insulin Degludec;Liraglutide	Injection	Biological Products(3.1)	Supplementary Application	2024-02-27		Novo Nordisk A/S			view
JXSS2000036	德谷胰岛素利拉鲁肽注射液	Insulin Degludec;Liraglutide	Injection	Biological Products(3.1)	Import Drug Application	2020-09-30	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd	Certificate Issued	2021-10-28	view
JXSS2000037	德谷胰岛素利拉鲁肽注射液	Insulin Degludec;Liraglutide	Injection	Biological Products(3.1)	Import Drug Application	2020-09-30	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd	Certificate Issued	2021-08-27	view